These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 27235536)

  • 1. Gene of the month: BAP1.
    Wang A; Papneja A; Hyrcza M; Al-Habeeb A; Ghazarian D
    J Clin Pathol; 2016 Sep; 69(9):750-3. PubMed ID: 27235536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z; Buljan M; Busam KJ
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAP1-deficient and VE1-negative atypical Spitz tumor.
    Requena C; Sanz V; Nagore E; García-Casado Z; Rubio L; Guillén C; Kutzner H
    J Cutan Pathol; 2015 Aug; 42(8):564-7. PubMed ID: 25953246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.
    Zhang AJ; Rush PS; Tsao H; Duncan LM
    J Cutan Pathol; 2019 Dec; 46(12):965-972. PubMed ID: 31233225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
    Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.
    Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P
    JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature.
    Wysozan TR; Khelifa S; Turchan K; Alomari AK
    J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
    Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
    J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
    Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
    Yélamos O; Navarrete-Dechent C; Marchetti MA; Rogers T; Apalla Z; Bahadoran P; Blázquez-Sánchez N; Busam K; Carrera C; Dusza SW; de la Fouchardière A; Ferrara G; Gerami P; Kittler H; Lallas A; Malvehy J; Millán-Cayetano JF; Nelson KC; Quan VL; Puig S; Stevens H; Thomas L; Marghoob AA
    J Am Acad Dermatol; 2019 Jun; 80(6):1585-1593. PubMed ID: 30244062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome.
    Busam KJ; Wanna M; Wiesner T
    JAMA Dermatol; 2013 Mar; 149(3):335-9. PubMed ID: 23552620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
    Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
    J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based analysis of germline BAP1 mutations in melanoma.
    O'Shea SJ; Robles-Espinoza CD; McLellan L; Harrigan J; Jacq X; Hewinson J; Iyer V; Merchant W; Elliott F; Harland M; Bishop DT; Newton-Bishop JA; Adams DJ
    Hum Mol Genet; 2017 Feb; 26(4):717-728. PubMed ID: 28062663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline BAP1 mutations predispose to malignant mesothelioma.
    Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M
    Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation.
    Gerami P; Yélamos O; Lee CY; Obregon R; Yazdan P; Sholl LM; Guitart GE; Njauw CN; Tsao H
    JAMA Dermatol; 2015 Nov; 151(11):1235-9. PubMed ID: 26154183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome.
    Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N
    Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
    Star P; Goodwin A; Kapoor R; Conway RM; Long GV; Scolyer RA; Guitera P
    Eur J Cancer; 2018 Mar; 92():48-53. PubMed ID: 29413689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.